NCT05680870View on ClinicalTrials.gov

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

December 5, 2024

Study Completion Date

December 12, 2024

Conditions
Chemotherapy Induced Peripheral Neuropathy
Interventions
DRUG

Omeprazole

Omeprazole 40 mg 3 times daily for 5 days ..to start 2 days before chemotherapy cycles

Trial Locations (1)

Unknown

Tanta university, Tanta

All Listed Sponsors
lead

Aya Mohamed Sadek Elsaid

OTHER